Relating to newborn screening tests for Duchenne muscular dystrophy.
Texas bill requiring newborn screening for Duchenne muscular dystrophy to enable earlier diagnosis and potential early intervention in affected infants.
Texas bill requiring newborn screening for Duchenne muscular dystrophy to enable earlier diagnosis and potential early intervention in affected infants.
HB 2295 requires Texas to add Duchenne muscular dystrophy (DMD) to the state's newborn screening panel. DMD is a severe, progressive genetic disorder that causes muscle weakness and degeneration, typically appearing in early childhood. Early detection through newborn screening could enable earlier intervention and treatment options.
Duchenne muscular dystrophy is a rare but devastating condition affecting approximately 1 in 3,500 male births. Early identification allows families to access genetic counseling, monitor disease progression, and potentially benefit from emerging therapies that may slow progression if started early. Texas's current newborn screening panel does not include DMD, meaning affected infants are typically diagnosed only after symptoms become apparent, potentially missing critical windows for treatment.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.